Markers on the map indicate study centers conducting IQVIA-sponsored clinical trials. Click on a map marker for more information about an individual study site.
Methylphenidate in Adults With Attention Deficit/Hyperactivity Disorder
Methylphenidate (MPH) is the first-line pharmacological treatment for adults with
Attention-Deficit/Hyperactivity Disorder (ADHD). Nevertheless, there is considerable
...
Want more information about clinical trials near you?
Register to get notifications about clinical trials in your area.
This website uses cookies, including those for the essential functioning of the site and
for analytical purposes. For more information about these cookies and the choices you have to manage them, please read our Privacy Policy or visit the Interactive Advertising Bureau.
By clicking through to the website, we understand this means you have accepted our cookies.
English (USA)